![A 23 gene–based molecular prognostic score precisely predicts overall survival of breast cancer patients - eBioMedicine A 23 gene–based molecular prognostic score precisely predicts overall survival of breast cancer patients - eBioMedicine](https://www.thelancet.com/cms/asset/e190074d-4d50-496d-bfc9-e7de74dfec2f/gr1.jpg)
A 23 gene–based molecular prognostic score precisely predicts overall survival of breast cancer patients - eBioMedicine
![New App Calculates Women's Risk for Advanced Breast Cancer | UCSF Helen Diller Family Comprehensive Cancer Center New App Calculates Women's Risk for Advanced Breast Cancer | UCSF Helen Diller Family Comprehensive Cancer Center](https://cancer.ucsf.edu/sites/cancer.ucsf.edu/files/styles/sf_large_width/public/2023-03/bcsc-app.jpg?itok=fRtA6mbs)
New App Calculates Women's Risk for Advanced Breast Cancer | UCSF Helen Diller Family Comprehensive Cancer Center
![New free breast cancer website helps sufferers to predict their survival chances - and how long they have left to live | Daily Mail Online New free breast cancer website helps sufferers to predict their survival chances - and how long they have left to live | Daily Mail Online](https://i.dailymail.co.uk/i/pix/2010/09/15/article-1312183-0B31EB7F000005DC-213_468x306.jpg)
New free breast cancer website helps sufferers to predict their survival chances - and how long they have left to live | Daily Mail Online
![Cancers | Free Full-Text | Predicting Prognosis of Breast Cancer Patients with Brain Metastases in the BMBC Registry—Comparison of Three Different GPA Prognostic Scores Cancers | Free Full-Text | Predicting Prognosis of Breast Cancer Patients with Brain Metastases in the BMBC Registry—Comparison of Three Different GPA Prognostic Scores](https://www.mdpi.com/cancers/cancers-13-00844/article_deploy/html/images/cancers-13-00844-g003.png)
Cancers | Free Full-Text | Predicting Prognosis of Breast Cancer Patients with Brain Metastases in the BMBC Registry—Comparison of Three Different GPA Prognostic Scores
![JPM | Free Full-Text | Clinical Utility of Gene Expression Profiling Data for Clinical Decision-Making Regarding Adjuvant Therapy in Early Stage, Node-Negative Breast Cancer: A Case Report JPM | Free Full-Text | Clinical Utility of Gene Expression Profiling Data for Clinical Decision-Making Regarding Adjuvant Therapy in Early Stage, Node-Negative Breast Cancer: A Case Report](https://www.mdpi.com/jpm/jpm-02-00071/article_deploy/html/images/jpm-02-00071-g001.png)
JPM | Free Full-Text | Clinical Utility of Gene Expression Profiling Data for Clinical Decision-Making Regarding Adjuvant Therapy in Early Stage, Node-Negative Breast Cancer: A Case Report
![Estimating mortality in women with triple-negative breast cancer: the 'ESTIMATE triple-negative' tool - ScienceDirect Estimating mortality in women with triple-negative breast cancer: the 'ESTIMATE triple-negative' tool - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0959804923002587-gr2b.jpg)
Estimating mortality in women with triple-negative breast cancer: the 'ESTIMATE triple-negative' tool - ScienceDirect
![Optimal Endocrine Therapy in Premenopausal Women: A Pragmatic Approach to Unanswered Questions | JCO Oncology Practice Optimal Endocrine Therapy in Premenopausal Women: A Pragmatic Approach to Unanswered Questions | JCO Oncology Practice](https://ascopubs.org/na101/home/literatum/publisher/asco/journals/content/op/2022/op.2022.18.issue-3/op.21.00482/20220303/images/large/op.21.00482t1.jpeg)
Optimal Endocrine Therapy in Premenopausal Women: A Pragmatic Approach to Unanswered Questions | JCO Oncology Practice
![Determination of breast cancer prognosis after neoadjuvant chemotherapy: comparison of Residual Cancer Burden (RCB) and Neo-Bioscore | British Journal of Cancer Determination of breast cancer prognosis after neoadjuvant chemotherapy: comparison of Residual Cancer Burden (RCB) and Neo-Bioscore | British Journal of Cancer](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41416-020-01251-3/MediaObjects/41416_2020_1251_Fig1_HTML.png)